Folakemi Odedina, Ph.D. (HEMO ’21), selected as a Lancet Oncology Commissioner

Folakemi Odedina, Ph.D. (HEMO ’21), Division of Hematology and Medical Oncology at Mayo Clinic in Florida, was selected as a Lancet Oncology Commissioner for Precision Oncology. Her team will work on the clinical challenges of implementing precision oncology across the globe. Dr. Odedina is a professor of oncology in the Mayo Clinic College of Medicine and Science.